Key Findings
Analysis of CIK cell products generated from five treatment-naïve mCRC patients identified 17 “Global Cell Clusters” (G) across 43,047 retained cells. These were grouped into seven main cell subtypes: CD8+ T cells, CD4+ T cells, Mixed CD4/CD8+ T cells, NK cells, γ9δ2 T cells, B cells, and Cycling T cells. The results confirm that the cell product is predominantly composed of αβ T cells, with cytotoxic CD8+ T cells serving as the primary expanded population critical for tumor clearance.
Technical Details
The researchers utilized unsupervised Louvain clustering and the top 100 differentially expressed genes (DEGs) to define transcriptional identities. Specific markers used for annotation included:
- T Cell Subtypes: CD3E for general T cells; CD4 and CD8A for specific lineages; MKI67 and cell cycle gene signatures for Cycling T cells.
- γ9δ2 T cells: Identified via TRDV2 and TRGV9 expression, with enrichment for ZBTB16 (encoding PLZF) and cytotoxicity genes such as GNLY, NKG7, and FCGR3A.
- NK and B cells: NK cells were characterized by NCAM1 and TYROBP1; B cells by CD19 and MS4A1.
Sub-analysis of 14,973 CD8 single-positive αβ T cells revealed 10 distinct clusters. Based on NCAM1 expression, these were divided into conventional (C0, C1, C2, C4, C6, C8) and NK-like (C3, C5, C7, C9) subtypes. Conventional clusters C0 and C1 exhibited memory-associated transcriptional cores (TCF7, IL7R, LEF1), with C0 showing interferon-stimulated genes (ISG20) and C1 showing hypoxia and glycolysis programs (HILPDA, BNIP3).
Background & Context
CIK cells are generated to leverage potent cell-killing capacities against tumors. While flow cytometry has previously indicated the composition of these products, this scRNA-seq approach allows for a more granular understanding of functional states, such as the identification of “Tc2-like” subtypes (C2) characterized by high GATA3, PTGDR2, IL13, and IL4 expression.
Significance & Outlook
By mapping the heterogeneity of CD8+ T cells—including the distinction between ISG+ Tcm-like and Tcm-like states—this atlas provides a transcriptional baseline for evaluating the composition and potential efficacy of CIK cell therapies in mCRC patients.
Source: https://doi.org/10.21203/rs.3.rs-11560858/v1
Get our weekly technology intelligence — free
Receive an infographic that lets you judge at a glance whether each field’s analysis report is worth reading.
Subscribe Free — Weekly Tech Intelligence
By subscribing, you’ll receive Troy-Technical’s weekly technology intelligence newsletter.
- Your email and selected fields are used only to deliver the newsletter.
- We never share your information with third parties.
- You can unsubscribe anytime via the link in each email.
See our Privacy Policy for details.
Takes about a minute · Unsubscribe anytime



